CMA vs PLRX
CMA (CMA) versus Pliant Therapeutics Inc (PLRX) — a side-by-side from cached financials, not a winner call.
CMA (CMA) common stock.
Pliant Therapeutics Inc (PLRX) is a biotechnology company listed on US.
CMA does not have a complete income-statement cache yet.
Latest reported PLRX revenue for 2024-12-31 was $0. Net income was -$210.3M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. PLRX currently screens at market cap $77.3M.
PLRX currently screens at market cap $77.3M.
Not investment advice. Open the CMA and PLRX stock pages for the full models.
Not investment advice.